INZY
Price
$4.00
Change
+$0.01 (+0.25%)
Updated
Jun 30 closing price
Capitalization
258.25M
38 days until earnings call
KROS
Price
$13.45
Change
+$0.04 (+0.30%)
Updated
Jul 3 closing price
Capitalization
546.28M
26 days until earnings call
Interact to see
Advertisement

INZY vs KROS

Header iconINZY vs KROS Comparison
Open Charts INZY vs KROSBanner chart's image
Inozyme Pharma
Price$4.00
Change+$0.01 (+0.25%)
Volume$1.46M
Capitalization258.25M
Keros Therapeutics
Price$13.45
Change+$0.04 (+0.30%)
Volume$148.11K
Capitalization546.28M
INZY vs KROS Comparison Chart in %
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. KROS commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and KROS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (INZY: $4.00 vs. KROS: $13.45)
Brand notoriety: INZY and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 53% vs. KROS: 22%
Market capitalization -- INZY: $258.25M vs. KROS: $546.28M
INZY [@Biotechnology] is valued at $258.25M. KROS’s [@Biotechnology] market capitalization is $546.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and KROS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 2 bearish.
  • KROS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, INZY is a better buy in the short-term than KROS.

Price Growth

INZY (@Biotechnology) experienced а 0.00% price change this week, while KROS (@Biotechnology) price change was -0.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

KROS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($546M) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 44.404 vs. KROS (-15.035). KROS has higher annual earnings (EBITDA): 14.8M vs. INZY (-100.34M). KROS has more cash in the bank: 721M vs. INZY (84.8M). KROS has less debt than INZY: KROS (18.4M) vs INZY (47M). KROS has higher revenues than INZY: KROS (215M) vs INZY (0).
INZYKROSINZY / KROS
Capitalization258M546M47%
EBITDA-100.34M14.8M-678%
Gain YTD44.404-15.035-295%
P/E RatioN/AN/A-
Revenue0215M-
Total Cash84.8M721M12%
Total Debt47M18.4M255%
TECHNICAL ANALYSIS
Technical Analysis
INZYKROS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 23 days ago
87%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADJEX16.770.24
+1.45%
Azzad Ethical
TCMSX41.610.48
+1.17%
Voya Small Cap Growth I
FMILX64.330.66
+1.04%
Fidelity New Millennium
MDSPX28.220.26
+0.93%
BlackRock Advantage SMID Cap Inv A
MGKCX13.530.08
+0.59%
Morgan Stanley Global Permanence C

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
ACAD - INZY
50%
Loosely correlated
-1.37%
VCYT - INZY
43%
Loosely correlated
N/A
KROS - INZY
43%
Loosely correlated
+0.30%
PRME - INZY
41%
Loosely correlated
+1.30%
AURA - INZY
37%
Loosely correlated
+1.55%
More